Mowat-Wilson syndrome (MWS) is a complex developmental syndrome caused by heterozygous mutations in the Zinc finger E-box-binding homeobox 2 gene (ZEB2). We generated the first human iPSC lines from primary fibroblasts of two siblings with MWS carrying a heterozygous ZEB2 stop mutation (c.1027C > T; p.Arg343*) using the Sendai virus reprogramming system. Both iPSC lines were free from reprogramming vector genes, expressed pluripotency markers and showed potential to differentiate into the three germ layers. Genetic analysis confirmed normal karyotypes and a preserved stop mutation. These iPSC lines will provide a useful resource to study altered neural lineage fate and neuropathophysiology in MWS.
Resource details
Mowat-Wilson syndrome (MWS) is characterized by intellectual disability, facial dysmorphisms, epilepsy, Hirschsprungs disease and various malformations derived from the neuronal and neuroectodermal lineages (Ivanovski et al., 2018) . The syndrome is caused by haploinsufficiency of the Zinc finger E-box-binding homeobox 2 (ZEB2), also known as Smad-interacting protein 1 (SIP1), acting as a transcription factor regulating neuronal, neuroectodermal and mesodermal lineage commitment in the early embryo. However, the mechanisms by which ZEB2 haploinsufficiency interferes with cell lineage fate and further neuronal differentiation are not fully understood. While investigations of mechanisms underlying MWS have been performed in mice (Stryjewska et al., 2017) , there is a lack of accessible human models to study the pathophysiology. To this end, we identified two siblings diagnosed with MWS syndrome both carrying an identical heterozygous ZEB2 germ-line mutation [c.1027C > T (p.Arg343Ter)]. We generated human iPSC lines from primary fibroblasts of both patients (MWS26, MWS27) using the Sendai virus reprogramming system. The two iPSC lines MWS26(B) and MWS27(7) were expanded as monolayers in tight colonies and showed typical iPSC morphology with large nucleus-to-cytoplasm ratio, prominent nuclei and defined luminescent borders as seen by Bright-field microscopy ( Fig. 1A ; size bar: 100 μm). Tables 1-3 Endogenous expression of the pluripotency markers NANOG, SOX2, TRA-1-60 and SSEA4 was demonstrated by flow cytometry (Fig. 1B ) and immunocytochemistry (Fig. 1C , size bar: 100 μm), respectively, in both iPSC lines. Cell authentication using a set of 16 polymorphic short tandem repeats (STRs) confirmed that the established iPSC lines matched the donor fibroblasts (data available upon request). Additionally, the two MWS patient derived iPSC lines MWS26(B) and MWS27 (7) were devoid of Sendai reprogramming vector confirmed by RT/PCR ( Fig. 1D) .
Analysis of the two iPSC lines using scorecards showed a pluripotency marker expression corresponding to an undifferentiated state using a reference set of 23 pluripotent stem cell lines ( Fig. 1E) (Fergus et al., 2016) . The differentiation potential of the two iPSC lines was assessed by embryoid body (EB) formation. Expression of specific markers for ectoderm, mesoderm and endoderm using scorecard analysis confirmed that the iPSC lines are capable of differentiating into the three germ layers ( Both of the iPSC lines MWS26(B) and MWS27(7) retained the pathogenic ZEB2 gene variant (c.1027C > T) of the donor as confirmed by Sanger sequencing (Fig. 1F ). Genomic integrity was investigated by karyotyping and no acquired chromosomal aberration was detected in any of the two iPSC lines (Fig. 1G ). Both iPSC lines tested free of Mycoplasma infection using MycoAlert™ Mycoplasma detection kit.
The two MWS syndrome patient derived iPSC lines generated here will offer a useful resource to study disease pathophysiology and 
Materials and methods

Culture conditions
Fibroblasts and feeder cells were cultured in DMEM, Sigma, cat no: D5796, 10% fetal bovine serum, ThermoFisher Scientific, cat no: 10500056, 2 mM GlutaMAX™, ThermoFisher Scientific, cat no: 35050038, 1% penicillin/streptomycin, ThermoFisher Scientific, cat no: 15140122 in a humidified atmosphere with 5% CO 2 at 37°C and passaged using TrypLE™ Express, ThermoFisher Scientific, cat no: 12604039, and Defined Trypsin Inhibitor, ThermoFisher Scientific, cat no: R007100.
hiPS cells were initially cultured (5%CO 2 , 37°C) in Knockout™ DMEM, ThermoFisher Scientific, cat no: 10829018, 20% KnockOut™ Serum Replacement, ThermoFisher Scientific, cat no: A3181501, 2 mM GlutaMAX™, 1% non-essential amino acids, 1% penicillin/streptomycin on human foreskin feeder layer and passaged mechanically. Subsequently, iPSC were cultured in Essential-8™ medium, ThermoFisher Scientific, cat no: A1517001, on Vitronectin-XF™, Stem Cell Technologies, cat no: 07180, coated plates and passaged with Gentle Cell Dissociation Reagent, Stem Cell Technologies, cat no: 07174. After passage P25, iPSC lines were adapted to culture on human Laminin-521, Biolamina, cat no: LN-521, and passaged using TrypLE™ Express and Defined Trypsin Inhibitor.
For embryonic body formation, iPSC were dissociated with accutase, Sigma cat no: A6964, seeded into an AggreWell™400 plate, Stem Cell Technologies, cat no: 34421, in AggreWell™ medium, Stem Cell Technologies, cat no: 05893, supplemented with 10 μM Rho-kinase inhibitor Y27632, Stem Cell Technologies, cat no: 72304 according to protocol. Embryoid bodies were transferred to non-adherent culture plates and further differentiated for four weeks.
Reprogramming
Fibroblasts were reprogrammed using CytoTune™-iPS 1.0 Sendai Reprogramming Kit, ThermoFisher Scientific, cat no: A16517, expressing the four Yamanaka factors Klf4, c-Myc, Sox2, Oct3/4. iPSC colonies were manually picked for passage 1 and clonally expanded with mechanical passaging on human feeder cells (Sobol et al., 2015) . Once established, iPSC lines were subsequently transferred to Vitronectin™-XL coated dishes and adapted to culture on LN-521 (see Culture Conditions) past passage 25.
Cell authentication
Cell authentication on DNA from fibroblasts and iPSC lines was performed at Eurofins Genomics, Germany using AmpFLSTR™ Identifiler™ PCR Amplification Kit, ThermoFisher Scientific, cat no: 4322288.
Genome stability
Genome stability was analyzed by karyotyping of individual metaphases and chromosomes were stained with Giemsa (G) solution. Analysis of G-banded chromosomes on fixed metaphases was performed using the Metafer slide scanning platform and Ikaros software, MetaSystems (Sobol et al., 2015) .
RT-PCR
The miRNeasy micro kit, Qiagen, cat no: 217084 was employed to prepare RNA samples from the iPSC lines. cDNA was synthesized from 1 μg of total RNA using High Capacity cDNA Synthesis kit, ThermoFisher Scientific, cat no: 4368814. Subsequently, 1/10 of the cDNA reaction was used for PCR. Assessment of persistent Sendai virus was performed by running 35 cycles of standard PCR (95°C -30 s, 55°C -1 min, 72°C -1 min) on a "MyCycler" thermal cycler, BIORAD, with primers SeV-F and SeV-R utilizing cDNA derived from the iPSC lines or without template (negative control), respectively. Alternatively, primers GAPDH-F and GAPDH-R were used (positive control).
PCR products (expected sizes SeV: 195 bp (SeV), GAPDH: 325 bp) were visualized by 1% agarose gel electrophoresis. Ladder: GeneRuler 100 bp DNA ladder, ThermoFisher Scientific, cat no: SM0243.
Immunofluorescence
Cells were fixed in 4% formaldehyde for 5 min and pre-incubated in 1xPBS, 1%BSA, 0,3% TritonX100. Fixed cells were subjected to antibody staining using primary antibodies (mouse anti-NANOG, rabbit anti-SOX2) at 4°C overnight followed by secondary antibodies (donkey anti-mouse AF647, donkey anti-goat AF488) at room temperature for 60 min. All antibodies were diluted in preincubation buffer. Subsequently, DAPI (1 μg/ml; nuclear marker), Sigma, cat no: D8417 was incubated for 10 min at room temperature and specimens were mounted onto microscope slides using CFM-3 mounting medium, Citifluor. An AxioImager (Zeiss) was used for imaging.
Flow cytometry
iPSCs were harvested with accutase, Sigma cat no: A6964, washed in 1%BSA/1xPBS and subsequently incubated with primary antibodies (mouse-IgG anti-SSEA4, mouse-IgM anti TRA-1-60) at room temperature for 30 min followed by incubation with secondary antibodies (goat anti-mouse IgM AF488, goat anti-mouse IgG AF555) for 20 min at room temperature. Cells were analyzed on a LSR-FORTESSA (BD).
Scorecard assay
RNA isolation was performed as described (RT/PCR) and RNA quality was assessed using RNA 6000 Nano Kit, Agilent, cat no: 5067-1511 and BioAnalyzer. cDNA samples (see RT/PCR) were run on TaqMan® hPSC Scorecard™ Panel, ThermoFisher Scientific, cat no: A15872/A15870 following manufacturer's protocol (Fergus et al., 2016) . Scorecards were analyzed with company's software at https:// apps.thermofisher.com/hPSCscorecard/home.htm.
Mycoplasma
The MycoAlert™ Mycoplasma Detection kit, Lonza, cat no: LT07-318 was used to test for the presence of mycoplasma in iPSC culture supernatants. Table 3 Reagents details. Schuster, et al. Stem Cell Research 39 (2019) 
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